Surgical Sutures And Staples Global Market Report 2024

The surgical sutures and staples market size has grown strongly in recent years. It will grow from $13.48 billion in 2023 to $14.7 billion in 2024 at a compound annual growth rate (CAGR) of 9.0%. The growth observed in the historic period can be attributed to several factors, including the aging population, increased surgical procedure volumes, improvements in healthcare infrastructure, and the rise of minimally invasive surgery (MIS). These factors collectively contributed to the expansion of the surgical sutures and staples market.

The surgical sutures and staples market size is expected to see strong growth in the next few years. It will grow to $20.27 billion in 2028 at a compound annual growth rate (CAGR) of 8.4%. The anticipated growth in the forecast period can be attributed to several factors, including the expansion of emerging markets, the development and adoption of biodegradable and bio-absorbable products, the integration of telemedicine and remote surgery solutions, and the increasing focus on value-based healthcare. Major trends expected in the forecast period include ongoing technological advancements, the customization of suture solutions to meet specific patient needs, the use of 3D printing and nanotechnology, and the integration of digital health technologies into the field of surgical sutures and staples. These trends reflect the evolving landscape of healthcare and the demand for advanced and patient-centric solutions.

The global increase in the number of surgical procedures serves as a significant catalyst for the surgical sutures and staples market. Surgeries are fundamental medical interventions used for repairing injuries, alleviating symptoms, restoring bodily functions, removing diseased organs, or replacing anatomical components. They are also performed in emergency situations, such as trauma, fractures, and acute infections. In the United States, for example, the Department of Health & Human Services reported 22 million surgeries, with 52.7% being outpatient procedures. The global estimate indicates a staggering 234 million surgeries performed annually worldwide.

The main categories within the surgical sutures and staples market include surgical sutures and surgical staples. Surgical staples are specialized fasteners used in surgical procedures to close skin wounds, connect tissues, or facilitate tissue removal. They encompass disposable surgical staplers and reusable surgical staplers. Surgical sutures, on the other hand, are categorized into absorbable and non-absorbable sutures. These products find applications in various healthcare settings, including hospitals, ambulatory surgical centers (ASCS), and clinics.

The surgical sutures and staples market research report is one of a series of new reports that provides surgical sutures and staples market statistics, including surgical sutures and staples industry global market size, regional shares, competitors with a surgical sutures and staples market share, detailed surgical sutures and staples market segments, market trends and opportunities, and any further data you may need to thrive in the surgical sutures and staples industry. This surgical sutures and staples market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The growth of chronic diseases is poised to drive the surgical sutures and staples market forward. Chronic diseases, also referred to as non-communicable diseases (NCDs), are persistent conditions that develop and persist over an extended period, often lasting for years or even a lifetime. Surgical sutures and staples are essential tools in medical procedures that may be necessary for managing or treating chronic diseases. They play a crucial role in closing wounds, securing tissues, and facilitating surgical interventions required to address complications, symptoms, or underlying issues associated with chronic diseases. Globally, non-communicable diseases (NCDs) are responsible for 74% of the 41 million annual deaths, with 17.9 million attributed to cardiovascular diseases, 9.3 million to cancer, 4.1 million to chronic respiratory diseases, and 2.0 million to diabetes, as reported by the World Health Organization. Hence, the increasing prevalence of chronic diseases propels the surgical sutures and staples market.

The growing adoption of minimally invasive surgeries presents a significant challenge for the surgical sutures and staples market. Minimally invasive surgery, a technique designed to minimize bodily harm during surgical procedures, offers advantages such as reduced pain, shorter hospital stays, and fewer complications compared to open surgery. As a result, the popularity of minimally invasive surgeries is on the rise, with more than 693,000 robotic-assisted procedures performed in the USA, of which approximately 86% are minimally invasive surgeries, as reported by iData Research.

An emerging trend in the surgical sutures and staples market is the utilization of disposable surgical sutures and staple devices. This trend is primarily driven by concerns regarding the transmission of communicable infections associated with reusable sutures and staple devices. Disposable surgical sutures and staple devices are designed for single-use, preventing any possibility of reuse. In line with this, the Centers for Disease Control and Prevention (CDC) promotes protocols to prevent pathogen spread and encourages the use of disposable devices.

Leading companies in the surgical sutures and staples market are dedicated to developing innovative products to boost their market revenues. One example is the ECHELON 3000 Stapler, a digitally-enabled device offering surgeons one-handed powered articulation, improving ease of use and control. Ethicon, a US-based manufacturer of surgical sutures and wound closure devices, introduced this digitally enabled stapler in June 2022. These devices are complemented by software providing real-time haptic and audible feedback to surgeons, enabling crucial adjustments during procedures.

In 2021, BD seals acquired Tissuemed, a surgical sealant manufacturer. This acquisition enhances the company's comprehensive surgical solutions portfolio, providing surgeons with advanced tools for suturing and stapling internal tissues. Tissuemed, based in the UK, specializes in self-adhesive film products that aid in sealing and suturing internal tissues.

Major companies operating in the surgical sutures and staples market include Ethicon Endo-Surgery Inc., Stryker Corporation, Smith & Nephew PLC, Conmed Corporation, Medtronic PLC, Johnson & Johnson, B.Braun Melsungen AG, Baxter International Inc., Alcon Laboratories Inc., Dextera Surgical Inc., Becton, Dickinson and Company, Cardica Inc., Purple Surgical Inc., Welfare Medical Ltd., Reach surgical Inc., Meril Life Science Pvt. Ltd., Frankenman International, Boston Scientific Corporation, Zimmer Holdings Inc., Intuitive Surgical Inc., CareFusion Corporation, 3M Company, CryoLife Inc., Derma Sciences Inc., DeRoyal Industries Inc., Teleflex Incorporated, DemeTECH Corporation, Sutures India Pvt. Ltd., Péters Surgical, EndoEvolution LLC, Surgical Specialties Corporation, Dolphin Sutures, Internacional Farmacéutica S.A. de C.V., AD Surgical, Apollo Endosurgery Inc., Assut Medical Sarl, Aspen Surgical Products Inc.

North America was the largest region in the global surgical sutures and staples market in 2023. Western Europe was the second-largest region in the surgical sutures and staples market share. The regions covered in the surgical sutures and staples market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the surgical sutures and staples market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The surgical sutures and staples market consists of sales of surgical sutures (absorbable, non-absorbable), and surgical staples (disposable surgical staplers, reusable surgical staplers). Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.